Screening for trisomies 21 and 18 in a Spanish public hospital: from the combined test to the cell-free DNA test-Reference-Cited by-同舟云学术

Screening for trisomies 21 and 18 in a Spanish public hospital: from the combined test to the cell-free DNA test

Published:2016-11-22 Issue:20 Volume:30 Page:2476-2482
ISSN:1476-7058
Container-title:The Journal of Maternal-Fetal & Neonatal Medicine
language:en
Short-container-title:The Journal of Maternal-Fetal & Neonatal Medicine

Author:

Gil M. M.¹,Brik M.¹,Casanova C.¹,Martin-Alonso R.¹,Verdejo M.¹,Ramírez E.²,Santacruz B.¹

Affiliation:

1. Department of Obstetrics and Gynecology, Torrejon University Hospital, Torrejon de Ardoz, Madrid, Spain and

2. Clinical Analysis Laboratory of Torrejon University Hospital, Unilabs®, Madrid, Spain

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/14767058.2016.1253062

Reference22 articles.

1. Screening for fetal aneuploidies at 11 to 13 weeks

2. Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities

3. Presence of fetal DNA in maternal plasma and serum

4. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis

5. Diagnóstico prenatal de los defectos congénitos. Cribado de las anomalías cromosómicas (actualizada 2010). Guías de Asistencia práctica. Sociedad Española de Ginecología y Obstetricia (SEGO). Available from: http://www.gapsego.com [last accessed 30 Apr 2016]

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does a High-Risk (>1/50) Result for First-Trimester Combined Screening Always Entail Invasive Testing? Which Patients from This Group Might Benefit from cfDNA Testing?;Biomedicines;2022-10-14

2. A Critical Evaluation of Validation and Clinical Experience Studies in Non-Invasive Prenatal Testing for Trisomies 21, 18, and 13 and Monosomy X;Journal of Clinical Medicine;2022-08-15

3. Clinical performance of DNA‐based prenatal screening using single‐nucleotide polymorphisms approach in Thai women with singleton pregnancy;Molecular Genetics & Genomic Medicine;2020-04-24

4. Antenatal screening for fetal trisomies using microarray‐based cell‐free DNA testing: A systematic review and meta‐analysis;Prenatal Diagnosis;2020-03

5. Clinical and Economic Evaluation after Adopting Contingent Cell-Free DNA Screening for Fetal Trisomies in South Spain;Fetal Diagnosis and Therapy;2020